Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1202068036

Citations Report

Citations Report - Journal of Leukemia [386 Articles]

The articles published in Journal of Leukemia have been cited 386 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Journal of Leukemia.

Huang L, Li H, Xie D, Shi T, Wen C. Personalizing Chinese medicine by integrating molecular features of diseases and herb ingredient information: application to acute myeloid leukemia. Oncotarget. 2017 Jun 27;8(26):43579.

Loarte P, Dashkova I, Tortez L, Dashkova A, Kozikowski A, Ibrahim R, Pekmezaris R. Understanding Unmet Needs in the Older Acute Myeloid Leukemia (AML) Patient. Current Cancer Therapy Reviews. 2016 Dec 1;12(4):246-52.

Radhakrishnan S, Syed R, Takei H, Kobayashi IS, Nakamura E, Sultana F, Kamal A, Tenen DG, Kobayashi SS. Styryl Quinazolinones and its ethynyl derivatives induce myeloid differentiation. Bioorganic & Medicinal Chemistry Letters. 2019 Jun 20.

Almarza CC. The clinical practice of embodied care: A phenomenological examination of physician-family interactions in oncological treatment (Doctoral dissertation, Education: Faculty of Education).

Almarza CC. The clinical practice of embodied care: A phenomenological examination of physician-family interactions in oncological treatment (Doctoral dissertation, Education: Faculty of Education).

Timilshina N, Breunis H, Tomlinson GA, Brandwein JM, Buckstein R, Durbano S, Alibhai SM. Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy. Leukemia. 2019 Jan;33(1):15.

Stein E, Xie J, Duchesneau E, Bhattacharyya S, Vudumula U, Ndife B, Bonifacio G, Guerin A, Li N, Joseph G. Cost effectiveness of midostaurin in the treatment of newly diagnosed flt3-mutated acute myeloid leukemia in the United States. PharmacoEconomics. 2019 Feb 13;37(2):239-53.

Liu FR, Jin H, Wang Y, Chen C, Li M, Mao SJ, Wang Q, Li H. Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia. Drug delivery. 2017 Jan 1;24(1):882-90.

Li Y, Zhang M, Sheng M, Zhang P, Chen Z, Xing W, Bai J, Cheng T, Yang FC, Zhou Y. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia. Journal of cancer research and clinical oncology. 2018 Jun 1;144(6):1065-77.

Özbolat G, Tuli A. Demir Fazlalığı Ä°çin Şelasyon Tedavisi ve Şelasyon Ligandları. Arşiv Kaynak Tarama Dergisi. 2019;28(1):66-81.

Santosh K. Review on Thalassemia. Biochemistry Molecular Biology Letters. 2017;3(2):1-0.

Darvishi-Khezri H, Salehifar E, Kosaryan M, Karami H, Alipour A, Shaki F, Aliasgharian A. The impact of silymarin on antioxidant and oxidative status in patients with β-thalassemia major: A crossover, randomized controlled trial. Complementary therapies in medicine. 2017 Dec 1;35:25-32.

Veloso AS. Micro RNAs e mieloma múltiplo (Doctoral dissertation).

Nicolas Batty MD. FACP FASCP, Young Yin PhD (2015) A Need of Metrics in Cancer Economics: Myth or Hope. J Can Epi Treat.;1(1):11-2.

GV RR. Types of Cancer and Surgery in Rats (Rattus norvegicus). growth.;91:95.

Manasa P. Journal of Oncology Research and Treatments. prostate. 2016;75:79.

Manasa P. Epigenetics–role as biomarker in cancer diagnosis. Adv. Oncol. Res. Treat. 2016;2:r001.

Nateghi B, Behshood P, Fathullahzadeh S, Mardanshah O. Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia. Research in Molecular Medicine. 2018 Dec 26;2017:rmm-v6i2.

Hershkovitz-Rokah O, Geva P, Salmon-Divon M, Shpilberg O, Liberman-Aronov S. Network analysis of microRNAs, genes and their regulation in diffuse and follicular B-cell lymphomas. Oncotarget. 2018 Jan 30;9(8):7928.

Shukla P. Umbilical cord preservation-A Review. Biochem Mol Biol Lett. 2017;3(1):109.

Relevant Topics

Top